Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 4/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7914851 | 0.83 | MEN1 (0.39) | CYP19A1CYP17A1NAAAMEN1KMT2A | |
| SCHEMBL17754131 | 0.81 | CYP19A1 (0.36) | CYP19A1CYP17A1NAAA | |
| SCHEMBL45476 | 0.80 | NAAA (0.40) | CYP19A1CYP17A1NAAAMEN1KMT2A | |
| SCHEMBL28138951 | 0.79 | NAAA (0.39) | CYP19A1CYP17A1NAAAMEN1KMT2A | |
| SCHEMBL17752177 | 0.78 | NPC1 (0.35) | MEN1KMT2AMAPK1ALDH1A1EPHX2 | |
| SCHEMBL17752178 | 0.78 | ALDH1A1 (0.44) | MEN1KMT2AALDH1A1EPHX2 | |
| SCHEMBL17752179 | 0.76 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL17752175 | 0.76 | MEN1 (0.47) | MEN1KMT2AALDH1A1EPHX2 | |
| Methacrylic Acid SCHEMBL13504160 | 0.76 | NAAA (0.37) | CYP19A1CYP17A1NAAAMEN1KMT2A | |
| SCHEMBL27627913 | 0.76 | NPSR1 (0.40) | CYP19A1CYP17A1NAAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9971241-B2 | Compound, resin, resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-15 | — | — | US | disclosed |
| US-20160139508-A1 | COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160139508-A1 | COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | AFF1, AFF2, AFF4 | CYP19A1 630/4885CYP17A1 1257/4885NAAA 3161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.